Avadel Pharmaceuticals plc stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Avadel Pharmaceuticals plc stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Avadel Pharmaceuticals plc do? Business model and key facts
Get the full picture of Avadel Pharmaceuticals plc: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees (FY): 188
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Stocks related to Avadel Pharmaceuticals plc
Selected based on industry alignment and relative market positioning.
Events and news impacting Avadel Pharmaceuticals plc stock
Earnings, coporate decisions and industry developments that can affect the share price.
Avadel Pharmaceuticals plc fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
